MYC and neoplasm: Enrichment of IntClust1, 2, and 9 subtypes linked to late recurrence, MYC amplification, and enhanced genomic instability further supports the notion that metastatic ER-positive breast cancer exhibits more aggressive tumor behavior compared to primary disease54.